Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Directorate Change

30 Oct 2023 07:00

RNS Number : 6216R
Aston Martin Lagonda Glob.Hldgs PLC
30 October 2023
 

30 October 2023

Aston Martin Lagonda Global Holdings plc

Appointment of Non-Executive Directors

Aston Martin Lagonda Global Holdings plc (the "Company" or "Aston Martin") announces the appointment of Jean Tomlin OBE as an Independent Non-Executive Director and member of the Nomination Committee. Jean is the founder and CEO of Chanzo Limited, a firm that provides consulting, operational delivery and international recruitment services to major event and sport sectors. Jean's previous roles include Director of Human Resources of the London Organising Committee of the Olympic and Paralympic Games, Group HR Director at Marks & Spencer plc and nine years at Ford Motor Company in various human resources management positions.

Jean currently serves as a Non-Executive Director of Capri Holdings Plc, a luxury fashion group where she chairs the Remuneration Committee. She was previously a Non-Executive Director of J Sainsbury Plc from 2013 to 2020.

The Company further announces the appointment of Cyrus Jilla as a Non-Independent Non-Executive Director. Cyrus is Group Managing Partner at B-FLEXION and represents Ernesto Bertarelli, a member of the Yew Tree Consortium which holds a total of 26.23% of the Company. 

Lawrence Stroll, Executive Chairman of Aston Martin, said: "I am delighted to welcome Jean and Cyrus to the Board. Jean's HR background combined with luxury and automotive sector experience will be of great benefit to the Board. Cyrus represents Ernesto Bertarelli, a significant member of the Yew Tree Consortium. I look forward to working with them both."

Jean Tomlin and Cyrus Jilla were appointed to the Board on 27 October 2023 with immediate effect.

The Company confirms that there is no further information to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules of the Financial Conduct Authority with regard to both appointments.

Enquiries

Investors and Analysts

Robert Berg

Investor Relations

+44 (0)7789 177547robert.berg@astonmartin.com 

Media

Kevin Watters

Director of Communications

+44 (0)7764 386683kevin.watters@astonmartin.com 

Paul Garbett

Head of Corporate and Brand Communications

+44 (0)7501 380799paul.garbett@astonmartin.com

Teneo

Harry Cameron

+44 (0)20 7353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPGMWUUPWGMB
Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.